IRUM ZIAUDDIN: Open Payments
NPI 1386686905 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 13 payments from 7 companies in 2025. Trend: 2023 $835 · 2024 $791 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $161 |
| Boston Scientific Corporation | 1 | $149 |
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 1 | $78 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
Products named: Ozempic, Kerendia, WATCHMAN Access System, TZIELD, AIRSUPRA, SPRAVATO, LEQVIO.
Industry payments across WI — which companies pay providers there.
